All Stories

  1. Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic Monitoring

    Article • Journal of Parkinson s Disease, December 2022, IOS Press

    Dr Manuela Contin

  2. Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort

    Article • Journal of Parkinson s Disease, April 2021, IOS Press

    Dr Manuela Contin

  3. Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy

    Article • Epilepsia, June 2018, Wiley

    Dr Manuela Contin

  4. Novel UHPLC-MS/MS method for the determination of rotigotine in the plasma of patients with Parkinson's disease

    Article • Biomedical Chromatography, February 2017, Wiley

    Dr Manuela Contin

  5. Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease

    Article • Movement Disorders, July 2015, Wiley

    Dr Manuela Contin